Patents by Inventor Mark Carlton
Mark Carlton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240102024Abstract: The present disclosure provides host cells, e.g., bacterial cells, that comprise a methionine decarboxylase enzyme for the treatment of diseases and disorders associated with methionine metabolism in a subject. The disclosure further provides pharmaceutical compositions and methods of treating disorders associated with methionine metabolism, such as homocystinuria.Type: ApplicationFiled: November 30, 2023Publication date: March 28, 2024Inventors: Dylan Alexander Carlin, Vincent M. Isabella, Jonathan McMurry, Theodore Carlton Moore, III, Mylene Perreault, Nathan Schmidt, Mark Simon
-
Publication number: 20170104441Abstract: A transportable power supply unit is disclosed comprising a load carrying support and an electrical storage arrangement on the support. At least two solar panels are mounted on the load carrying support, each of which is interchangeable between a retracted configuration and a deployed configuration. The load carrying support comprises a base and a rectangular support frame projecting up above the base having four sides. In some forms the unit further includes a post mounted on the base that is extendible between a collapsed configuration for transport and an extended configuration projecting above the support frame. A security camera may be mounted on an upper end of the post.Type: ApplicationFiled: October 7, 2016Publication date: April 13, 2017Inventor: MARK CARLTON SWAN
-
Patent number: 7879564Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.Type: GrantFiled: December 21, 2006Date of Patent: February 1, 2011Assignee: Takeda Pharmaceutical Company LimitedInventors: Nicola Brice, Mark Carlton, John Dixon, Alan Hendrick, Isabelle Malinge, Sophie Messager, Dirk Zahn
-
Publication number: 20100272647Abstract: We disclose BACH G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO. 3 or SEQ ID NO: 5, and homologues, variants and derivatives thereof Nucleic acids capable of encoding BACH polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID No. 1, SEQ ID No.2 or SEQ ID NO: 4 or a mouse BACH genomic sequence (SEQ ID NO: 10).Type: ApplicationFiled: November 4, 2009Publication date: October 28, 2010Applicant: Takeda Pharmaceutical Co. Ltd.Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
-
Publication number: 20100158807Abstract: We disclose a method of treating or preventing a disease selected from the group consisting of: a bladder disease, a bladder disorder, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, including overflow and urge incontinence, urinary urge, cystitis, including interstitial cystitis and overactive bladder.Type: ApplicationFiled: October 7, 2009Publication date: June 24, 2010Applicant: TAKEDA PHARMACEUTICAL CO. LTD.Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
-
Publication number: 20100087241Abstract: One aspect is directed to a system whereby a live gaming table system is provided with one or more handheld user input devices which, for example, may allow multiple different players to simultaneously or concurrently provide wager input data and/or other data to the gaming table system. In at least one embodiment, the handheld user input devices may form part of a multi-player touch input interface system which is operable to identify or determine where, who, and what transactions are taking place at a multi-player gaming table and/or multi-player gaming system.Type: ApplicationFiled: October 2, 2008Publication date: April 8, 2010Applicant: IGTInventors: Binh T. Nguyen, Rick Rowe, Mark Carlton Nicely, Bryan Wolf, Brian Underdahl
-
Publication number: 20090187996Abstract: The present invention relates to a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of pain, the method comprising determining whether a candidate molecule is an agonist or antagonist, including a opener, blocker or modulator, of Kv9.2 polypeptide, in which the Kv9.2 polypeptide comprises the amino acid sequence shown in SEQ ID NO:3 or SEQ ID NO:5, or a sequence which is at least 90% identical thereto.Type: ApplicationFiled: October 29, 2007Publication date: July 23, 2009Inventors: Nicola Brice, Mark Carlton, John Dixon, Isabelle Malinge, Dirk Zahn
-
Publication number: 20070248545Abstract: We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.Type: ApplicationFiled: December 21, 2006Publication date: October 25, 2007Inventors: Nicola Brice, Mark Carlton, John Dixon, Alan Hendrick, Isabelle Malinge, Sophie Messager, Dirk Zahn
-
Publication number: 20070166230Abstract: Provided are Kv9.2 polypeptides comprising the amino acid sequence shown in SEQ ID NO. 3 or SEQ ID NO: 5, and homologues, variants and derivatives thereof. Nucleic acids capable of encoding Kv9.2 polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID No. 1, SEQ ID No.2 or SEQ ID NO: 4. Methods of identifying Kv9.2 agonists and antagonists are also provided.Type: ApplicationFiled: October 30, 2006Publication date: July 19, 2007Inventors: Nicola Brice, Mark Carlton, John Dixon, Isabelle Malinge, Dirk Zahn
-
Publication number: 20060242724Abstract: The present invention relates to novel functions of a known receptor. In particular, the invention relates to the use of a sphingosylphosphorylcholine receptor and/or ligands thereof in the manipulation of the neuronal and limbic systems and diagnosis and treatment of pain.Type: ApplicationFiled: March 20, 2006Publication date: October 26, 2006Inventors: Mark Carlton, John Dixon, Alan Hendrick, Sophie Messager, Dirk Zahn, Jennifer Horwood
-
Publication number: 20050160486Abstract: We disclose a method of treating or preventing a disease selected from the group consisting of: a bladder disease, a bladder disorder, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, including overflow and urge incontinence, urinary urge, cystitis, including interstitial cystitis and overactive bladder.Type: ApplicationFiled: July 27, 2004Publication date: July 21, 2005Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
-
Publication number: 20050064549Abstract: We disclose Conrad G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 14 or SEQ ID NO: 17 and homologues, variants and derivatives thereof. Nucleic acids capable of encoding Conrad polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 16 or SEQ ID NO: 18.Type: ApplicationFiled: April 16, 2004Publication date: March 24, 2005Inventors: Samuel Aparicio, Mark Carlton, Philip Mitchell
-
Publication number: 20050026825Abstract: We disclose Mowgli G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 8, and homologues, variants and derivatives thereof. Nucleic acids capable of encoding Mowgli polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 7 or SEQ ID NO: 10.Type: ApplicationFiled: November 14, 2003Publication date: February 3, 2005Inventors: Mark Carlton, Samuel Aparicio, John Dixon, Rosemary Thresher, Dirk Zahn
-
Publication number: 20040025199Abstract: We disclose BACH G-protein coupled receptor (GPCR) polypeptides comprising the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5, and homologues, variants and derivatives thereof. Nucleic acids capable of encoding BACH polypeptide are also disclosed, in particular, those comprising the nucleic acid sequences shown in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 4 or a mouse BACH genomic sequence (SEQ ID NO:10).Type: ApplicationFiled: May 6, 2003Publication date: February 5, 2004Inventors: Samuel Aparicio, Mark Carlton, John Dixon, Sophie Messager, Andreas Russ, Rosemary Thresher
-
Patent number: D505732Type: GrantFiled: January 6, 2004Date of Patent: May 31, 2005Assignee: Hector Tile Company, Inc.Inventors: Mark Carlton Anderson, Dwight David Anderson, Paul Newton Anderson
-
Patent number: D506013Type: GrantFiled: May 12, 2004Date of Patent: June 7, 2005Assignee: Hector Tile Company, Inc.Inventors: Mark Carlton Anderson, Dwight David Anderson, Paul Newton Anderson
-
Patent number: D511845Type: GrantFiled: May 12, 2004Date of Patent: November 22, 2005Assignee: Hector Title Company, Inc.Inventor: Mark Carlton Anderson
-
Patent number: D515710Type: GrantFiled: March 22, 2005Date of Patent: February 21, 2006Assignee: Hector Tile Company, Inc.Inventors: Mark Carlton Anderson, Dwight David Anderson, Paul Newton Anderson
-
Patent number: D521654Type: GrantFiled: March 22, 2005Date of Patent: May 23, 2006Assignee: Hector Tile Company, Inc.Inventors: Mark Carlton Anderson, Dwight David Anderson, Paul Newton Anderson